Maximising use of population data on cardiometabolic diseases

Abstract

The worldwide burden of adult cardiometabolic diseases such as hypertension, diabetes, obesity, and dyslipidaemia continues its relentless increase. Scaling up the prevention, management, and control of cardiometabolic diseases is cost-effective but requires strong health systems.1 As we have previously argued in this journal,2 building these health systems requires data that is accurate, timely, and transparent. Data from high-quality population-based surveys are particularly essential, as they reflect the spectrum of adults living in communities, including those who are not reached by their health system.